Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infection

Abstract

The HIL mouse provides a model for the understanding of HCV-specific human immune responses and HCV-associated disease pathologies. It could also serve as a platform for antifibrosis and immune-modulatory drug testing.